000 | 01090 a2200277 4500 | ||
---|---|---|---|
005 | 20250514205240.0 | ||
264 | 0 | _c20050222 | |
008 | 200502s 0 0 eng d | ||
022 | _a0733-2459 | ||
024 | 7 |
_a10.1002/jca.20020 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFerrero, Simone | |
245 | 0 | 0 |
_aVEGF levels in patients with peripheral arterial occlusive disease receiving LDL-apheresis. _h[electronic resource] |
260 |
_bJournal of clinical apheresis _c2004 |
||
300 |
_a160; author reply 161 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 |
_aArterial Occlusive Diseases _xblood |
650 | 0 | 4 | _aBlood Component Removal |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xbiosynthesis |
650 | 0 | 4 |
_aLipoproteins, LDL _xmetabolism |
650 | 0 | 4 |
_aPeripheral Vascular Diseases _xblood |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xbiosynthesis |
773 | 0 |
_tJournal of clinical apheresis _gvol. 19 _gno. 3 _gp. 160; author reply 161 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/jca.20020 _zAvailable from publisher's website |
999 |
_c15182764 _d15182764 |